| Metric | FY 2025↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.2B | $2.0B | $1.3B | $0.1B | $0.3B | $0.3B | $0.3B |
| Cost of Revenue | $0.3B | $0.3B | $0.3B | $0.2B | $0.0B | $0.1B | $0.1B | $0.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.2B | $0.3B | $0.3B | $0.2B | $-0.3B | $0.1B | $0.2B | $0.2B |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $-0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $1.49 | $2.94 | $2.83 | $2.26 | $-1.19 | $0.82 | $0.77 | $0.88 |
| EPS (Diluted) | $1.46 | $2.88 | $2.79 | $2.21 | $-1.19 | $0.80 | $0.75 | $0.85 |
| Metric | FY 2025↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.0B | $3.8B | $3.8B | $2.3B | $2.4B | $2.4B | $1.3B | $1.2B |
| Current Assets | $0.1B | $0.1B | $0.3B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Cash & Equivalents | $0.0B | $0.0B | $0.2B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B |
| Stockholders' Equity | $0.1B | $0.3B | $0.4B | $0.3B | $0.2B | $0.2B | $0.4B | $0.4B |
| Metric | FY 2025↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.4B | $0.4B | $0.3B | $-0.0B | $0.3B | $0.3B | — |
| Investing Cash Flow | $-0.5B | $-0.3B | $-1.1B | $-0.1B | $-0.1B | $-0.2B | $-0.2B | — |
| Capital Expenditures | $0.5B | $0.3B | $0.2B | $0.1B | $0.1B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $0.2B | $-0.2B | $0.8B | $-0.2B | $0.1B | $-0.1B | $-0.1B | — |